期刊文献+

ACOS患者血D-二聚体及纤维蛋白原临床观察 被引量:9

Clinical significance of plasma D-dimer,fibrinogen in patients with asthma and copd overlap syndrome
下载PDF
导出
摘要 目的探讨哮喘和慢阻肺重叠综合症(ACOS)患者中血D-二聚体、纤维蛋白原的临床变化情况。方法选取ACOS患者(ACOS组)40例,单纯慢性阻塞性肺疾病患者(单纯慢阻肺阻)40例,健康体检者(健康体检组)40例,测定各组血D-二聚体、纤维蛋白原含量,进行统计学比较分析。结果 ACOS组患者血D-二聚体及纤维蛋白原含量分别为(3.93±3.96)μg/ml、(6.26±2.24)g/L,明显高于单纯慢阻肺组的(2.25±0.94)μg/ml、(5.42±0.95)g/L,差异有统计学意义(P<0.05);而ACOS组和单纯慢阻肺组患者的血D-二聚体及纤维蛋白原含量均高于健康体检者,差异均有显著统计学意义(P<0.01)。结论 ACOS患者较单纯慢阻塞性肺疾病患者存在更明显的血栓前状态,血D-二聚体、纤维蛋白原可以评估ACOS患者发生血栓性疾病的危险性及判断预后。 Objective To investigate the c1inica1 changes of serum D-dimer,fibrinogen for the patients with asthma and copd over1ap syndrome(ACOS). Methods Forty patients with ACOS,40 patients with COPD were random1y se1ected. The serum D-dimer,fibrino-gen 1eve1s of the two groups were determined which compared with 40 hea1thy persons. Results The serum D-dimer,fibrinogen 1eve1s in ACOS,COPD groups were higher than the hea1thy group(P 〈 0. 01). The ACOS 1eve1 was higher than the COPD 1eve1(P 〈 0. 05). Conclusion The prothrombotic state obvious1y exists in ACOS than in COPD. The 1eve1 of serum D-dimer,fibrinogen in ACOS can detect thrombotic diseases and eva1uate the prognosis.
出处 《临床军医杂志》 CAS 2015年第12期1230-1232,共3页 Clinical Journal of Medical Officers
关键词 哮喘和慢阻肺重叠综合症 D-二聚体 纤维蛋白原 血栓 Asthma and copd overlap syndrome D-dimer Fibrinogen Thrombus
  • 相关文献

参考文献12

  • 1American Thoracic Society.Standards for diagnosis and care of patients with chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,1995,152:S77-S121. 被引量:1
  • 2Soriano JB,Davis KJ,Coleman B,et al.The proportional Venn diagram of obstructive lung disease:two approximations from the United States and the United Kingdom[J].Chest,2003,124:474-481. 被引量:1
  • 3De Marco R,Pesce G,Marcon A,et al.The coexistence of asthma and chronic obstructive pulmonary disease(COPD):prevalence and risk factors in young,middle-aged and elderly people from the general population[J].PLo S One,2013,8:e62985. 被引量:1
  • 4Shaya FT,Dongyi D,Akazawa MO,et al.Burden of concomitant asthma and COPD in a Medicaid population[J].Chest,2008,134:14-19. 被引量:1
  • 5Iwamoto H,Gao J,Koskela J,et al.Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap[J].Eur Respir J,2014,43:421-429. 被引量:1
  • 6Kitaguchi Y,Komatsu Y,Fujimoto K,et al.Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma[J].Int J Chron Obstruct Pulmon Dis,2012,7:283-289. 被引量:1
  • 7Cowan DC,Cowan JO,Palmay R,et al.Effects of steroid therapy on inflammatory cell subtypes in asthma[J].Thorax,2010,65:384-390. 被引量:1
  • 8Hurst JR,Vestbo J,Anzueto A,et al.Susceptibility to exacerbationin chronic obstructive pulmonary disease[J].N Engl J Med,2010,363(12):1128-1138. 被引量:1
  • 9陈峻,胡必成,崔天盆.慢性阻塞性肺疾病患者血浆D-二聚体、纤维蛋白原及纤维蛋白(原)降解产物检测的临床意义[J].中国医师进修杂志,2014,37(25):5-6. 被引量:17
  • 10Bonten TN,Kasteleyn MJ,Taube C,et al.The clinical management of COPD exacerbations:an update[J].Expert Rev Clin Pharmacol,2015,29:1-3. 被引量:1

二级参考文献5

共引文献16

同被引文献74

引证文献9

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部